Investment
Features
FeesSafety
Academy
More
Pluang+

Abacus Global Management to report Q2 2026 earnings on August 6 with a conference call.

Company Fundamentals
17 Jul 2026
Na
View Source
Neutral
pluang ai news

Abacus Global Management, a financial services firm specializing in alternative asset management, will release its second quarter 2026 financial results after market close on August 6, 2026. The company will host a conference call at 5:00 pm Eastern Time to discuss the results, accessible via webcast and phone. This earnings report is significant as it provides insight into Abacus's performance and growth in longevity-based assets and wealth solutions. Investors and analysts will closely watch the call for updates on the company's strategy and financial health.

More News

Jackery launches FridgeGuard, a smart fridge backup power, now exclusive at Costco.

Jackery launches FridgeGuard, a smart fridge backup power, now exclusive at Costco.

Jackery has introduced FridgeGuard, the world's slimmest refrigerator backup power system, now available exclusively at Costco. Designed to protect refrigerators during power outages, it offers up to 15 hours of backup runtime, covering the average U...

Market News
Bullish
17 minutes ago
Goodfirms launches guide to build prediction marketplaces with 100+ vetted vendors and clear cost ranges.

Goodfirms launches guide to build prediction marketplaces with 100+ vetted vendors and clear cost ranges.

Goodfirms has introduced the Prediction Marketplace Platform Vendor Recipe, a comprehensive guide that maps over 100 verified vendors across 20 technology categories and four build phases, with costs ranging from $25,000 to over $2 million. This reso...

Others
Neutral
1 hour ago
Mass spectrometry market to double to $14.09B by 2035, driven by pharma and biotech growth

Mass spectrometry market to double to $14.09B by 2035, driven by pharma and biotech growth

The global mass spectrometry market, valued at $6.68 billion in 2025, is projected to grow to $14.09 billion by 2035 at a CAGR of 7.74%. Growth is fueled by increased adoption in pharmaceutical manufacturing, biotechnology research, clinical diagnost...

Market News
Bullish
1 hour ago
New report details 1,859 clinical-stage pharma and biotech deals since 2020 with financial terms and contract insights

New report details 1,859 clinical-stage pharma and biotech deals since 2020 with financial terms and contract insights

ResearchAndMarkets.com released a comprehensive report covering over 1,859 clinical-stage partnering deals in pharmaceuticals and biotechnology from 2020 to 2026. The report includes detailed financial terms such as upfront payments, milestones, and ...

Others
Neutral
1 hour ago
Cancer biomarkers market to hit $54.48B by 2032, driven by tech advances and Asia-Pacific growth

Cancer biomarkers market to hit $54.48B by 2032, driven by tech advances and Asia-Pacific growth

The global cancer biomarkers market is projected to grow from $28.25 billion in 2026 to $54.48 billion by 2032, at an 11.6% CAGR. Growth is fueled by rising cancer rates, technological advances like multi-omics and AI integration, and increased deman...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App